National Institutes of Health: Dermatitis trials

The registry lists 29 Dermatitis studies with National Institutes of Health as lead sponsor. 1 are open to participants now and 7 have results posted.

Early Phase 1 1Phase 1 8Phase 2 6Phase 4 1No phase 17(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Effects of Treatments on Atopic DermatitisRecruitingNCT01631617Phase 2
• Targeted Investigation of Microbiome EliminationTerminatedNCT05177328Phase 1Results posted
• Effect of Dupilumab (Anti-IL4Rα) on the Host-Microbe Interface in Atopic DermatitisTerminatedNCT03389893Phase 4Results posted
• Targeted Microbiome Transplant in Atopic DermatitisCompletedNCT03151148Phase 1/2Results posted
• Atopic Dermatitis Research Network (ADRN) Influenza Vaccine StudyCompletedNCT01737710Not applicableResults posted
• Topical MTS-01 for Dermatitis During Radiation and Chemotherapy for Anal CancerTerminatedNCT01324141Phase 1Results posted
• Analysis of Response of Subjects With Atopic Dermatitis or Psoriasis to Oral Vitamin D3CompletedNCT00789880Phase 2Results posted
• Immune Response to Yellow Fever Vaccination in Adults With Atopic DermatitisCompletedNCT00723489Phase 1/2Results posted
• Safety and Efficacy of Tofacitinib for Chronic Granulomatous Disease With Inflammatory ComplicationsCompletedNCT05104723Phase 1/2
• Atopic Dermatitis (AD) and Food AllergyCompletedNCT03168113
• Beginning Assessment of Cutaneous Treatment Efficacy of Roseomonas in Atopic DermatitisCompletedNCT03018275Phase 1/2
• ADRN Barrier/Immunoprofiling Exploratory Pilot StudyCompletedNCT02115399
• Atopic Dermatitis Research Network (ADRN) Influenza Vaccine PilotCompletedNCT01518478Early Phase 1
• Registry for the Atopic Dermatitis Research NetworkCompletedNCT01494142
• Interferon Responses in Eczema HerpeticumCompletedNCT01429311
• Natural History of Severe Allergic Inflammation and ReactionsCompletedNCT01164241
• A Pilot Study Using Anakinra/Kineret for the Treatment of Patients With Severe Atopic DermatitisTerminatedNCT01122914Phase 1
• The Underlying Mechanisms For S. Aureus Infection And Colonization Of Skin in People With Atopic Dermatitis With And Without Eczema Herpeticum (MRSA)CompletedNCT00822276
• Responses to Immunization With Keyhole Limpet Hemocyanin Administered by Scarification and the Intradermal RouteCompletedNCT00614731Phase 1
• Evaluation and Long-Term Follow-Up of Patients With Allergic and Inflammatory DisordersTerminatedNCT00557895
• Identifying Genetic Determinants of Eczema Herpeticum and Other Viral Infections in Individuals With Atopic DermatitisCompletedNCT00515047
• Identifying Risk Factors for Eczema Herpeticum in Individuals With Atopic DermatitisCompletedNCT00438022
• Comparison of Cathelicidin Expression in Skin and Saliva in Patients With Atopic Dermatitis and PsoriasisCompletedNCT00407979
• Role of Antimicrobial Peptides in Host Defense Against Vaccinia VirusCompletedNCT00407069
• Immune Response to Varicella Vaccination in Children With Atopic DermatitisCompletedNCT00406081
• A Study of Familial and Genetic Aspects of Adult T-Cell: Leukemia/Lymphoma , Tropical Spastic Paraparesis, and Infective DermatitisCompletedNCT00340821
• Assessment of Digital Imaging as a Tool for Diagnosing Psoriasis, Hand Rashes and Unusual MolesCompletedNCT00005781
• Cytokine Production Patterns in Patients With Systemic Mastocytosis Compared With Atopic Dermatitis and Healthy IndividualsCompletedNCT00001760
• Induction of Suction Blisters in Patients With Urticaria, Blistering Diseases, Inflammatory Dermatoses and Neoplastic Disorders, and in Normal VolunteersCompletedNCT00001150